Eyal Kalo

979 total citations
10 papers, 663 citations indexed

About

Eyal Kalo is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Eyal Kalo has authored 10 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 2 papers in Cell Biology. Recurrent topics in Eyal Kalo's work include Cancer-related Molecular Pathways (4 papers), Cancer-related gene regulation (3 papers) and Epigenetics and DNA Methylation (2 papers). Eyal Kalo is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Cancer-related gene regulation (3 papers) and Epigenetics and DNA Methylation (2 papers). Eyal Kalo collaborates with scholars based in Israel, Australia and United States. Eyal Kalo's co-authors include Varda Rotter, Naomi Goldfinger, Perry Stambolsky, Yosef Buganim, Lilach Weisz, Shalom Madar, Hilla Solomon, Ido Goldstein, Ira Kogan and Ran Brosh and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Cancer Cell.

In The Last Decade

Eyal Kalo

10 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eyal Kalo Israel	9	464	334	157	102	55	10	663
Llorenç Coll-Mulet Spain	11	452 1.0×	263 0.8×	93 0.6×	67 0.7×	32 0.6×	12	663
Shih‐Hsin Lu China	19	574 1.2×	214 0.6×	202 1.3×	58 0.6×	27 0.5×	27	835
Kolaparthi Venkatasubbarao United States	14	588 1.3×	405 1.2×	177 1.1×	95 0.9×	15 0.3×	17	789
Marissa Shrader United States	9	380 0.8×	292 0.9×	158 1.0×	62 0.6×	30 0.5×	15	628
Yoko Ogawara Japan	6	445 1.0×	213 0.6×	118 0.8×	52 0.5×	20 0.4×	14	591
Stephanie Cabarcas‐Petroski United States	13	616 1.3×	311 0.9×	278 1.8×	54 0.5×	18 0.3×	23	840
J G Guillem United States	10	240 0.5×	370 1.1×	199 1.3×	134 1.3×	60 1.1×	11	706
Ira Kogan-Sakin Israel	13	523 1.1×	447 1.3×	261 1.7×	51 0.5×	74 1.3×	13	869
Morihisa Akagi Japan	15	336 0.7×	255 0.8×	142 0.9×	77 0.8×	20 0.4×	22	699

Countries citing papers authored by Eyal Kalo

Since Specialization

Citations

This map shows the geographic impact of Eyal Kalo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eyal Kalo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eyal Kalo more than expected).

Fields of papers citing papers by Eyal Kalo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eyal Kalo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eyal Kalo. The network helps show where Eyal Kalo may publish in the future.

Co-authorship network of co-authors of Eyal Kalo

This figure shows the co-authorship network connecting the top 25 collaborators of Eyal Kalo. A scholar is included among the top collaborators of Eyal Kalo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eyal Kalo. Eyal Kalo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Solomon, Hilla, Yosef Buganim, Tsevi Beatus, et al.. (2012). Various p53 mutant types differently regulate the Ras circuit to induce a cancer-related gene signature. Journal of Cell Science. 125(Pt 13). 3144–52. 58 indexed citations

Kalo, Eyal, Ira Kogan-Sakin, Hilla Solomon, et al.. (2012). Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high ROS levels. Journal of Cell Science. 125(Pt 22). 5578–86. 93 indexed citations

Buganim, Yosef, Shalom Madar, Yoach Rais, et al.. (2011). Transcriptional activity of ATF3 in the stromal compartment of tumors promotes cancer progression. Carcinogenesis. 32(12). 1749–1757. 36 indexed citations

Buganim, Yosef, Hilla Solomon, Yoach Rais, et al.. (2010). p53 Regulates the Ras Circuit to Inhibit the Expression of a Cancer-Related Gene Signature by Various Molecular Pathways. Cancer Research. 70(6). 2274–2284. 64 indexed citations

Buganim, Yosef, Ido Goldstein, Doron Lipson, et al.. (2010). A Novel Translocation Breakpoint within the BPTF Gene Is Associated with a Pre-Malignant Phenotype. PLoS ONE. 5(3). e9657–e9657. 49 indexed citations

Stambolsky, Perry, Yuval Tabach, Giulia Fontemaggi, et al.. (2010). Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53. Cancer Cell. 17(3). 273–285. 196 indexed citations

Stambolsky, Perry, Yuval Tabach, Giulia Fontemaggi, et al.. (2010). Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53. Cancer Cell. 17(5). 523–523. 7 indexed citations

Milyavsky, Michael, Igor Shats, Ran Brosh, et al.. (2007). Inactivation of Myocardin and p16 during Malignant Transformation Contributes to a Differentiation Defect. Cancer Cell. 11(2). 133–146. 61 indexed citations

Kalo, Eyal, Yosef Buganim, Naomi Goldfinger, et al.. (2007). Mutant p53 Attenuates the SMAD-Dependent Transforming Growth Factor β1 (TGF-β1) Signaling Pathway by Repressing the Expression of TGF-β Receptor Type II. Molecular and Cellular Biology. 27(23). 8228–8242. 68 indexed citations

10.

Buganim, Yosef, Eyal Kalo, Ran Brosh, et al.. (2006). Mutant p53 Protects Cells from 12- O -Tetradecanoylphorbol-13-Acetate–Induced Death by Attenuating Activating Transcription Factor 3 Induction. Cancer Research. 66(22). 10750–10759. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact